Research Catalog
New! Try our Article Search to discover online journals, books, and more from home with your library card.
Displaying 1-50 of 148 results
Physicians' genRx.
- Text
- Smithtown, N.Y. : Data Pharmaceutica Inc., c1993-c1997.
- 1993-1997
- 6 Items
Item details Format Call Number Item Location Text JSM 94-132 1995 Offsite Item details Format Call Number Item Location Text JSM 94-132 1996 Offsite Item details Format Call Number Item Location Text JSM 94-132 1997 Offsite PDR generics.
- Text
- Montvale, NJ : Medical Economics, c1995-
- 1995-present
- 3 Items
Item details Format Call Number Item Location Text JBM 97-181 4TH ED. Schwarzman Building - General Research Room 315 Available - Can be used on site. Please visit New York Public Library - Schwarzman Building to submit a request in person.
Item details Format Call Number Item Location Text JBM 97-181 1996 Schwarzman Building - General Research Room 315 Available - Can be used on site. Please visit New York Public Library - Schwarzman Building to submit a request in person.
Item details Format Call Number Item Location Text JBM 97-181 1997 Schwarzman Building - General Research Room 315 Available - Can be used on site. Please visit New York Public Library - Schwarzman Building to submit a request in person.
Mosby's genRx.
- Text
- St. Louis : Mosby, c1998-c2001.
- 1998-2001
- 4 Items
Item details Format Call Number Item Location Text JBM 99-819 v. 9 (1999) Schwarzman Building - General Research Room 315 Available - Can be used on site. Please visit New York Public Library - Schwarzman Building to submit a request in person.
Item details Format Call Number Item Location Text JBM 99-819 v. 10 (2000) Schwarzman Building - General Research Room 315 Available - Can be used on site. Please visit New York Public Library - Schwarzman Building to submit a request in person.
Item details Format Call Number Item Location Text JBM 99-819 v. 11 (2001) Schwarzman Building - General Research Room 315 Available - Can be used on site. Please visit New York Public Library - Schwarzman Building to submit a request in person.
How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry / The Congress of the United States, Congressional Budget Office ; [written by Anna Cook under the supervision of Jan Paul Acton and Elliot Schwartz].
- Text
- [Washington, D.C.] : The Office, [1998]
- 1998
- 1 Item
Item details Format Call Number Item Location Text JBF 98-693 Offsite Generic Drug Enforcement Act of 1991 : report (to accompany H.R. 2454) (including cost estimate of the Congressional Budget Office).
- Text
- [Washington, D.C.? : U.S. G.P.O., 1991]
- 1991
FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
- Text
- Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992.
- 1992
Role of commissioner of food and drugs : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on examining the role of the current commissioner of the Food and Drug Administration, March 6, 1991.
- Text
- Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992.
- 1992
FDA management and enforcement : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, September 12, 1991.
- Text
- Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992.
- 1992
Skyrocketing prescription drug costs : effects on senior citizens : hearing before the Special Committee on Aging, United States Senate, One Hundred Second Congress, second session, Lewiston, ME, April 15, 1992.
- Text
- Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992 [i.e. 1993]
- 1993
Pharmaceutical patent issues : interpreting GATT : hearings before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, second session ... S. 1277, a bill to provide equitable relief for the generic drug industry, and for other purposes, February 27, and March 5, 1996.
- Text
- Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1997.
- 1997
Mosby's drug consult.
- Text
- St. Louis : Mosby, c2002-
- 2002-present
- 9 Items
Item details Format Call Number Item Location Text JSM 03-65 2006 Offsite Item details Format Call Number Item Location Text *WSC-3082 2007 Offsite Item details Format Call Number Item Location Text JSM 03-65 2007 Offsite Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002.
- Text
- Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office], 2002.
- 2002
Hexal-Kapitalismus : der Aufstieg der Brüder Strüngmann / Heide Neukirchen.
- Text
- Frankfurt/Main ; New York : Campus, c2006.
- 2006
- 1 Item
Item details Format Call Number Item Location Text JFD 06-10537 Offsite Re: New York Health Insurance Program generic pricing for drugs from out-of-state pharmacies : report 2001-S-52.
- Text
- [2002]
- 2002
- 1 Item
Item details Format Call Number Item Location Text JBX F-5172 Offsite Full committee hearing on Medicaid drug reimbursements : are CMS cuts bad medicine for small businesses and beneficiaries? / Committee on Small Business, United States House of Representatives.
- Text
- Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007.
- 2007
- 1 Resource
Available Online
http://purl.access.gpo.gov/GPO/LPS90037Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, March 26, 2007.
- Text
- Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
- 2008
- 1 Resource
Available Online
http://purl.access.gpo.gov/GPO/LPS94138Assessing the impact of a safe and equitable biosimilar policy in the United States : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007.
- Text
- Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
- 2008
- 1 Resource
Available Online
http://purl.access.gpo.gov/GPO/LPS94188Trends in brand name and generic prescribed medicine utilization and expenditures, 1999 to 2003 / Marie N. Stagnitti.
- Text
- [Rockville, Md.] : Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality, [2006]
- 2006
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/LPS102485An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the Animal Drug User Fee Program, to Establish a Program of Fees Relating to Generic New Animal Drugs, to Make Certain Technical Corrections to the Food and Drug Administration Amendments Act of 2007, and for Other Purposes.
- Text
- [Washington, D.C.] : [U.S. G.P.O], [2008]
- 2008
- 2 Resources
Available Online
See All Available Online Resources
Animal Generic Drug User Fee Act of 2008 : report (to accompany H.R. 6433) (including cost estimate of the Congressional Budget Office).
- Text
- [Washington, D.C. : U.S. G.P.O., 2008]
- 2008
- 2 Resources
Available Online
See All Available Online Resources
Frecuentes preguntas acerca de las drogas genéricas.
- Text
- [Rockville, Md.] : Dept. of Health and Human Services, U.S. Food and Drug Administration, Center for Drug Evaluation and Research, [2004]
- 2004
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/LPS109938Medicamentos, entre el derecho y el mercado : estudio sobre acceso y uso racional de medicamentos en el Ecuador / [autores, Juan Cuvi, Patricia Benavides, Diego Obando].
- Text
- Quito : Corporación Acción Vital, 2009.
- 2009
- 1 Item
Item details Format Call Number Item Location Text ReCAP 10-36733 Offsite Protecting Consumer Access to Generic Drugs Act of 2007 [microform] : hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, on H.R. 1902, May 2, 2007.
- Text
- Washington : U.S. G.P.O., 2007.
- 2007
Guidance for industry : 180-day generic drug exclusivity under the Hatch-Waxman amendments to the Federal Food, Drug, and Cosmetic Act.
- Text
- Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [1998]
- 1998
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/LPS120164Preserve Access to Affordable Generics Act [microform] : report together with minority views (to accompany S. 369) (including cost estimate of the Congressional Budget Office).
- Text
- [Washington, D.C. : U.S. G.P.O., 2010]
- 2010
Committee prints on administration legislative proposals on the Animal Drug User Fee Act Amendments of 2008 and the Animal Generic Drug User Fee Act of 2008 [microform] : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, June 5, 2008.
- Text
- Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
- 2008
H.R. 1706, the Protecting Consumer Access to Generic Drugs Act of 2009 [microform] : hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, March 31 2009.
- Text
- Washington : U.S. G.P.O., 2012.
- 2012
Drug pricing : research on savings from generic drug use / [John E. Dicken].
- Text
- Washington, DC : U.S. Govt. Accountability Office, [2012]
- 2012
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo25638An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs and Medical Devices, to Establish User-Fee Programs for Generic Drugs and Biosimilars, and for Other Purposes.
- Text
- [Washington, D.C.] : [U.S. G.P.O.], [2012]
- 2012
- 2 Resources
Available Online
See All Available Online Resources
Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
- Text
- [Washington, D.C.] : U.S. Government Printing Office, [2013]
- 2013
Reauthorization of animal drug user fees : ADUFA and AGDUFA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, April 9, 2013.
- Text
- Washington : U.S. Government Printing Office, 2013.
- 2013
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo46363Reauthorization of animal drug user fees : ADUFA and AGDUFA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, April 9, 2013.
- Text
- [Washington, District of Columbia] : U.S. Government Printing Office, [2014]
- 2014
Medicare Part D, prescription drug benefit : increasing use and access of affordable prescription drugs : a report of the Special Committee on Aging, United States Senate.
- Text
- Washington : U.S. Government Publishing Office, 2014.
- 2014
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo54587Medicare Part D, prescription drug benefit : increasing use and access of affordable prescription drugs : a report of the Special Committee on Aging, United States Senate.
- Text
- Washington : U.S. Government Publishing Office, 2014.
- 2014
Closing the coverage gap : Medicare prescription drugs are becoming more affordable.
- Text
- [Baltimore, Maryland] : Centers for Medicare & Medicaid Services, [2015]
- 2015
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo58205The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period / Luke M. Olson, Brett W. Wendling.
- Text
- Washington, DC : Bureau of Economics, Federal Trade Commission, 2013.
- 2013
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo62909Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014.
- Text
- Washington : U.S. Government Publishing Office, 2016.
- 2016
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo66684FDA has made progress on oversight and inspections of manufacturers of generic drugs.
- Text
- [Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2015.
- 2015
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo68611Generic drug utilization in state Medicaid programs.
- Text
- [Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2006.
- 2006
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo69159Generic drug utilization in the Medicare Part D program.
- Text
- [Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2007.
- 2007
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo69109Medicare payments for newly available generic drugs.
- Text
- [Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2011.
- 2011
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo69263The impact of high-priced generic drugs on Medicare and Medicaid.
- Text
- [Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 1998.
- 1998
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo69530Perspectives of drug manufacturers : abbreviated new drug applications.
- Text
- [Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, Office of Evaluation and Inspections, 1990.
- 1990
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo69754The Food and Drug Administration's generic drug review process.
- Text
- [Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2008.
- 2008
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo71055Pay-for-delay deals : limiting competition and costing consumers : hearing before the Subcommittee on Antitrust, Competition Policy and Consumer Rights of the Committee on the Judiciary, United States Senate, One Hundred Thirteenth Congress, first session, July 23, 2013.
- Text
- Washington : U.S. Government Printing Office, 2013.
- 2013
Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014.
- Text
- Washington : U.S. Government Publishing Office, 2016.
- 2016
Special report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-patent prescription drugs : the monopoly business model that harms patients, taxpayers, and the U.S. health system.
- Text
- Washington : U.S. Government Publishing Office, 2016.
- 2016
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo76062Expanding the use of generic drugs.
- Text
- Washington, DC : Office of the Assistant Secretary for Planning and Evaluation, Office of Science and Data Policy, U.S. Department of Health and Human Services, 2010.
- 2010
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo78272Developments in the prescription drug market : oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016.
- Text
- Washington : U.S. Government Publishing Office, 2017.
- 2017
- 1 Resource
Available Online
https://purl.fdlp.gov/GPO/gpo82526
No results found from Digital Research Books Beta
Digital books for research from multiple sources world wide- all free to read, download, and keep. No Library Card is Required. Read more about the project.
